News

Yahoo Finance2mon
Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration
Boston (March 6, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a ...
Yahoo Finance5mon
Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Dec. 18, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that an abstract highlighting final clinical and biomarker data from its Phase 2 clinical ...
Nasdaq5mon
Coherus BioSciences Initiates Phase 2 Study of Casdozokitug Combined with Toripalimab and Bevacizumab for Liver Cancer Treatment
Coherus BioSciences has launched a randomized Phase 2 study to evaluate the efficacy of casdozokitug (casdozo), an IL-27-antagonistic antibody, combined with toripalimab and bevacizumab for ...
ascopubs.org12mon
A randomized phase 2 trial of the IO102-IO103 (IDO and PD-L1) cancer vaccine plus pembrolizumab as neoadjuvant/adjuvant treatment of patients with solid tumors.
A phase I pilot study of personalized neoantigen peptide-based vaccine in combination with pembrolizumab in advanced solid tumors (PNeoVCA). This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...